Showing results (51-60 of 6,811) with videos related to

Sort By:
Pageof 682
Cancer Research|January 1, 1994
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosineT Ueda, K Kamiya, Y Urasaki, et al.
Anticancer Research|May 1, 1988
DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicinS Ando, K Kamiya, T Yoshimura, et al.
Cancer Research|July 1, 1983
Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemiaT Ueda, T Nakamura, S Ando, et al.
Leukemia|April 1, 1997
Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapyT Nakamura, R Takauji, K Kamiya, et al.
International Journal of Hematology|April 4, 2000
Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemiaS Kishi, A Yoshida, T Yamauchi, et al.
Internal Medicine (Tokyo, Japan)|July 1, 1993
Crow-Fukase syndrome associated with pulmonary hypertensionH Iwasaki, K Ogawa, H Yoshida, et al.
Ophthalmic Research|January 1, 1996
Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eyeT Ueda, T Ueda, D Armstrong
Cancer Chemotherapy and Pharmacology|January 1, 1989
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignanciesT Ueda, T Nakamura, D Kagawa, et al.
Cancer Treatment Reports|July 1, 1986
Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cellsS Ando, T Nakamura, D Kagawa, et al.
Nihon Gan Chiryo Gakkai Shi|January 20, 1990
[Clinical effect and pharmacokinetics of intermediate dose Ara-C therapy in a patient with acute non-lymphocytic leukemia with two CNS recurrences]T Fukushima, T Ueda, K Kamiya, et al.
Pageof 682